Cargando…
What is the Impact of the Analysis Method Used for Health State Utility Values on QALYs in Oncology? A Simulation Study Comparing Progression-Based and Time-to-Death Approaches
BACKGROUND: Health state utility values (‘utilities’) are an integral part of health technology assessment. Though traditionally categorised by disease status in oncology (i.e. progression), several recent assessments have adopted values calculated according to the time that measures were recorded b...
Autores principales: | Hatswell, Anthony J., Bullement, Ash, Schlichting, Michael, Bharmal, Murtuza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060240/ https://www.ncbi.nlm.nih.gov/pubmed/33314001 http://dx.doi.org/10.1007/s40258-020-00620-6 |
Ejemplares similares
-
Evaluation of survival extrapolation in immuno-oncology using multiple pre-planned data cuts: learnings to aid in model selection
por: Bullement, Ash, et al.
Publicado: (2020) -
Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma
por: Bullement, Ash, et al.
Publicado: (2019) -
Cost-Effectiveness Analysis of Recombinant Factor VIII Fc-Fusion Protein (rFVIIIFc) for the Treatment of Severe Hemophilia A in Italy Incorporating Real-World Dosing and Joint Health Data
por: Bullement, Ash, et al.
Publicado: (2019) -
A QALY loss is a QALY loss is a QALY loss: a note on independence of loss aversion from health states
por: Lipman, Stefan A., et al.
Publicado: (2018) -
The PROMIS of QALYs
por: Hanmer, Janel, et al.
Publicado: (2015)